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ABSTRACT
The visual outcomes of vitrectomy in a series of five eyes of three patients with vitreous haemorrhage due to Terson 
syndrome were retrospectively evaluated. There were two bilateral cases and one unilateral. The neurological dia-
gnosis included cranio-cerebral trauma and cerebral aneurysm rupture. The mean time interval between intracranial 
haemorrhage and vitrectomy was nine months (range 7–10 months). Pars plana vitrectomy was performed with 
BSS as a tamponade in three eyes, SF6 gas in one eye, and silicone oil in one eye. The mean follow-up period was 12 
months (range 1–27 months). Visual acuity improved significantly in all patients from counting fingers to the mean 
value of 0.6 (range 0.1–1.0). We observed one epiretinal membrane, one tractional retinal detachment, and two 
cataract formations. The best visual outcomes were achieved with BSS as a tamponade, the worst was with silicone 
oil as a tamponade and retinal detachment. Performing vitrectomy with BSS as a tamponade in patients with Terson 
syndrome significantly improves visual acuity, so early diagnosis and surgical treatment are crucial.
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INTRODUCTION
Terson syndrome is defined as a haemorrhage 
in the eye associated with earlier intracranial bleed-
ing [1]. Intraretinal haemorrhage associated with 
subarachnoid bleeding was first described by Litten 
in 1881, but the case described in 1900 by the 
French ophthalmologist Albert Terson was named 
as this syndrome [2–4]. Nowadays, according to 
this definition, this syndrome comprises all forms 
of intraocular haemorrhage associated with intrac-
ranial bleeding or raised intracranial pressure (ICP). 
Haemorrhage occurring during the course of Terson 
syndrome may be present in one or both eyes [2]. 
Clinical symptoms include blurred vision, which 
correlates with the severity of bleeding, usually with 
characteristic intracranial haemorrhage neurological 
symptoms, such as loss of consciousness and coma. 
Terson syndrome occurs in 10-20% of patients who 
experience subarachnoid haemorrhage, but is less 
likely to be associated with subdural haematoma 
or traumatic epidural haematoma or resulting from 
other causes [5]. Differential diagnosis should in-
clude another cause of intraocular bleeding as dia-
betic retinopathy, age-related macular degeneration 
(AMD), intraocular tumour, or retinal detachment 
[2]. Ophthalmic examinations, diagnosis, and pos-
sible treatment (mainly surgical) can reduce the 
likelihood of subsequent visual impairments or loss 
of vision.
Below we present the results of surgical treatment 
with vitrectomy of three patients with diagnosed 
Terson syndrome — two bilateral and one unilateral.
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CASE 1
A 33-year-old woman was diagnosed with in-
traocular bilateral vitreous haemorrhage due to cer-
ebral trauma accompanied with quadriplegia six 
months previously. On admission to the hospital 
the best-corrected visual acuity (BCVA) was hand 
movements in the right eye and counting fingers to 
one metre in the left eye. Intraocular pressure (ICP) 
and anterior segment of both eyes were normal. 
Ultrasonography (USG) of the eyeball confirmed 
haemorrhage into the vitreous cavity, and a diagno-
sis of Terson syndrome was made (Fig. 1). Planned 
surgery under general anaesthesia was delayed be-
cause the patient had taken drugs with monoam-
ine oxidase inhibitors. After psychiatric consulta-
tion and change of treatment, a month later (eight 
months after trauma) vitrectomy was performed 
with balanced salt solution (BSS) as endotampon-
ade on the left eye. BCVA before the surgery was 
hand movements and on discharge from the hos-
pital it was 0.1. Another control, a month later, 
showed further improvement in vision of the left 
eye to 0.4. One month after vitrectomy with BSS 
as endotamponade was performed on the left eye, 
the same procedure was carried out on the right eye. 
Postoperatively, BCVA was counting 0.2 without 
correction. Two months after second vitrectomy 
BCVA was 0.3 in the right eye and 0.8 in the 
left eye.
CASE 2
A 48-ear-old man presented with subvitreous 
haemorrhage in the left eye as a consequence of 
cerebral aneurysm rupture and stroke. BCVA was 
a 1.0 in the right eye and counting fingers to one 
metre in the left eye. Anterior segment and intraoc-
ular pressure of both eyes were correct. First, a cat-
aract surgery of the left eye was performed due to 
poor lens translucency. A month later (10 months 
after the neurological incident), vitrectomy was 
done with BSS as endotamponade. Postoperative-
ly, BCVA of the left eye was 0.3, after two weeks 
— 0.5, and after a month — 0.7 (Figs. 2, 3).
CASE 3
A 36-year-old man presented with the haemor-
rhage into the vitreous of both eyes, as a result of 
cerebral aneurysm rupture. On admission to the 
hospital, BCVA was counting fingers to 2 metres 
in both eyes. Seven months after the neurological 
incident, vitrectomy was performed in the right 
eye with ILM peeling due to the presence of epiret-
inal membrane and gas SF6 as endotamponade. 
The control examination after one month indicated 
BCVA as 0.8 in the right eye. After three months, 
a vitrectomy was performed in the left eye with 
simultaneous intraocular lens implantation due to 
cataract formation and 5000 cst silicone oil as end 
tamponade due to the presence of haemorrhage 
and retinal tractional detachment. Further control 
after one month brought improvement of BCVA to 
0.1. Due to the presence of proliferative vitreoretin-
opathy, a year after the operation on the left eye, 
a second vitrectomy was performed with silicone oil 
replacement and relaxing retinotomy. The vision of 
the left eye was still maintained at the level of 0.1, 
and IOP is correct. After two years, BCVA of the 
right eye was 0.7 and on the left eye — counting 
fingers to four metres.
DISCUSSION
Intraocular bleeding accompanying cerebral 
haemorrhage may be subretinal, intraretinal, epiret-
inal, subvitreal, or intravitreal [3]. The most com-
mon form of bleeding is subvitreal haemorrhage 
associated with subarachnoid haemorrhage (SAH) 
— 10–50%. Simultaneous haemorrhages into vitre-
ous and retina occur in about 18–20% of cases, with 
the least likely (4%) being haemorrhage into the vit-
reous humour only [6]. Most often, this syndrome 
is described as a correlation of subarachnoid haem-
orrhages with ruptured cerebral vessel aneurysms, 
mainly in three locations: in the internal carotid 
artery, the middle cerebral artery bifurcation, and 
in the upper part of the basal artery. The anatomical 
FIGURE 1. Ultrasonography of the eyeball with vitreous haemor-
rhage in the course of Terson syndrome
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aging examination (CT, computed tomography; 
MRI, magnetic resonance imaging; angio-CT, an-
gio-computed tomography) providing evidence of 
intracranial injury, neurological examination of eyes 
functions should be done. Terson syndrome can be 
confirmed by ophthalmic examination as fundus ex-
amination and ultrasonography of the eyeball [6]. If 
the view of the fundus is not possible, to determine 
the degree of vitreous haemorrhage, ultrasonogra-
phy examination (B-scan) is needed; it can also 
exclude detachment of the retina [3].
Clinical studies have shown the importance of 
early CT examination in detecting subarachnoid 
haemorrhage with simultaneous vitreous haemor-
rhage. Among a series of positive results of CT 
examination there were visible hyperdense areas 
— nodular or crescent — on the surface of the 
retina. Although these results cannot be illustrated 
in all patients, (some are poorly visualised), they can 
suggest the presence of intraocular haemorrhage [9].
Available methods for the treatment of Terson 
syndrome include conservative treatment and sur-
gery. In cases of minor bleeding into the vitreous 
cavity or preretinal bleeding spontaneous resorption 
location of the aneurysm (or vascular anomalies) 
is not associated with the site in which the Terson 
syndrome appears. It has also been proven that an-
atomical proximity between the aneurysm and the 
eyeball is not required for intraocular haemorrhage 
appearance [7]. In other reports such reasons are de-
scribed: trauma, hypertension, tumour, and periop-
erative and postoperative intracranial bleeding [3].
So far, the pathogenesis of Terson syndrome 
remains unclear. According to the most proba-
ble mechanism, the leading cause of bleeding is 
increased ICP, which causes oedema of the optic 
nerve. The blood returns from the retinal veins into 
the cavernous sinus with greater difficulty, and as 
a result the vessels of the retina and the choroid at 
the level of plaque sieve become closed. Increased 
intracranial venous pressure generated in the retinal 
veins causes stasis and rupturing of superficial reti-
nal vessels, leading to the intraocular haemorrhage. 
This theory explains the occurrence of Terson syn-
drome in cases other than subarachnoid haemor-
rhage [2, 5, 8].
Diagnostics of Terson syndrome usually begins 
with extended neurological tests. After neuroim-
FIGURE 2. Ocular coherence tomography of the macula before 
vitrectomy in a patient with Terson syndrome
FIGURE 3. Ocular coherence tomography of the macula after 
vitrectomy in a patient with Terson syndrome
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often occurs; this can take a few months (mean nine 
months). In the initial stage of the conservative 
treatment of lying patients, a higher position of the 
head is suggested, as well as avoidance of anticoagu-
lants (e.g. warfarin and aspirin).
In our case series vitrectomy was performed in 
all cases with good visual outcomes (Tab. 1). Vitrec-
tomy is recommended as beneficial in Terson syn-
drome since the 1970s. Indications for vitrectomy 
are as follows: long-lasting (4–6 months) haemor-
rhage, [2, 9], monocular patients, cases of bleeding 
in the macular region, bleeding with simultaneous 
retinal detachment, and bilateral and paediatric 
cases [2]. Kuhn et al. analysed 124 cases from the 
literature and found good visual outcomes and a rel-
atively low rate of complications. French researchers 
retrospectively evaluated the efficacy of vitrectomy 
as a method of treatment of Terson syndrome. They 
found that the prognosis regarding to the visual acu-
ity depends on many factors, including significant 
late effects of this syndrome (epiretinal membrane 
formation), as well as complications of the vitrec-
tomy (nuclear cataract and endophthalmitis). Also, 
they proved that final visual acuity affects the neu-
rological condition of the patient (damage to brain 
structures associated with Terson syndrome). [2, 9]. 
The authors of some studies have shown that anoth-
er factor that influences the prognosis is the age of 
the patient [2, 4].
Gnanaraj et al. found postoperative develop-
ment of cataract in 36% of patients in a retro-
spective study of 25 eyes [9]. We observed cataract 
preoperatively in two eyes, so cataract extraction 
was performed before vitrectomy in one case and 
as a combination with vitrectomy in another case. 
Gnanaraj recommended vitrectomy for the eyes 
with denser vitreous haemorrhages due to more rapid 
visual recovery in these eyes. He also recommended 
that funduscopy should be part of the routine exam-
ination of patients with intracranial haemorrhage in 
order to prevent referral delay. Other reports suggest 
an early vitrectomy in bilateral cases and an observa-
tion period of 3–6 months in unilateral cases. In bi-
lateral cases, an early vitrectomy often results in rapid 
visual rehabilitation that gives the patient a better 
chance of general recovery [11, 12].
A relative contraindication to surgery is low in-
tensity of haemorrhage, which is particularly likely 
to be spontaneously resorbed. If the patient’s clinical 
condition is severe, the surgery is contraindicated.
An alternative procedure is the use of an argon 
laser Nd: YAG, which forms a hole in the posterior 
membrane of the corpus vitreous and facilitates 
the evacuation of the contents of a haematoma 
localised preretinal to the corpus vitreous cavity. 
It helps further resorption of blood in the follow-
ing few months and finally improves visual acu-
ity [2,  4]. The authors of some publications do 
not recommend this method due to the potential 
development of future retinal folds or epiretinal 
membrane [3]. Another example of a less invasive 
method (rarely used in practice) is to apply intravit-
really an antibody IgG anti-RhD. The absorption of 
the vitreous haemorrhage depends on the degree of 
haemolysis of erythrocytes. Administration of anti-
body IgG anti-RhD accelerates this process. RhD 
antigens are specific to red blood cells, and their 
application does not result in so damage to other 
tissues. This method of treatment can be used only 
in Rh positive patients, which limits its use [2].
As complications we observed cataract forma-
tion, epiretinal membrane, and tractional retinal 
detachment. The most common complication of 
Terson syndrome is the formation of epiretinal 
Table 1. Eye, age, gender, interval from incident to vitrectomy, pre-/postoperative best-corrected visual 
acuity (BCVA), and pre-/postoperative observations of 5 eyes of 3 patients which underwent vitrectomy 
due to Terson syndrome
Case Eye Age 
(years)
Gender Interval from incident to 
vitrectomy (months)
Preop 
BCVA
Pre-/postoperative 
observations
Postop 
BCVA
Follow-up 
period
1 Right 33 Female 9 HM None 0.3 2
1 Left 33 Female 8 CF to 1m None 0.8 3
2 Left 48 Male 10 CF to 1m Cataract 0.7 1
3 Right 36 Male 7 CF to 2m Epiretinal membrane 0.8 24
3 Left 36 Male 10 CF to 2m Retinal detachment
Proliferative 
vitreoretinopathy
Cataract
0.1 27
HM — hand movement; CF — counting fingers
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membranes, observed in approximately 27–78% 
of cases. Results from clinical trials suggest that in 
cases of large and long-existing haemorrhage, some 
retinal damage may be caused by toxic effects of iron 
from red blood cells [13]. Intraocular bleeding can 
lead to proliferation of fibroblasts or glial cells. The 
resulting retinal folds or epiretinal membranes can 
significantly impair vision after resorption of haem-
orrhage. Ritland et al. recommend close follow-up 
in Terson syndrome with consideration of surgical 
intervention as soon as epiretinal membrane forma-
tion is found in ultrasonography, so that prolifera-
tive vitreoretinopathy (PVR) can be treated in its 
early stage [12]. Other late complications include: 
decline of retinal pigment epithelium, atrophy the 
optic nerve, macular hole, retinal folds, cysts of the 
retina, cataract, and PVR (3,12).
There is a clear correlation between morbidity 
and mortality due to the intracranial haemorrhage 
(SAH mainly) and the occurrence of intraocular 
haemorrhage, confirmed with a large number of 
studies and observations. In the course of Terson 
syndrome, a vitreous haemorrhage is saddled with 
3–9-fold higher mortality than haemorrhage to oth-
er places inside the eyeball [3]. Some studies suggest 
that the presence of blood inside the eye may be 
a sign of re-bleeding aneurysm [5, 7]. The occur-
rence of intraocular haemorrhage signals a serious 
clinical condition of patient’s after brain haemor-
rhage.
CONCLUSIONS
The occurrence of Terson syndrome is closely 
correlated with the serious condition of the patient 
and poor prognosis with regard to the consequenc-
es of the increase of intracranial pressure [1]. Al-
though some patients reveal spontaneous resorption 
of blood in the eye, many require specialised eye 
care, especially those with bilateral involvement. 
Performing vitrectomy with BSS as a tamponade 
in patients with Terson syndrome significantly im-
proves visual acuity, so early diagnosis and surgical 
treatment are crucial.
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